[{"address1": "2051 Ringwood Avenue", "city": "San Jose", "state": "CA", "zip": "95131", "country": "United States", "phone": "408 457 3700", "website": "https://www.ranitherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes RT-102, a parathyroid hormone that is in Phase I clinical trial for the treatment of osteoporosis; RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat psoriatic arthritis; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; RT-116 which is in discovery stage for the treatment of obesity; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. The has a collaboration agreement with ProGen Co., Ltd. for the o-development and commercialization of RT-114 to treat obesity. Rani Therapeutics Holdings, Inc. was founded in 2012 and is headquartered in San Jose, California.", "fullTimeEmployees": 105, "companyOfficers": [{"maxAge": 1, "name": "Mr. Mir A. Imran", "age": 69, "title": "Executive Chairman", "yearBorn": 1956, "fiscalYear": 2024, "totalPay": 40000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Talat  Imran", "age": 44, "title": "CEO & Director", "yearBorn": 1981, "fiscalYear": 2024, "totalPay": 105818, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Svai S. Sanford", "age": 55, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 416000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mir  Hashim", "age": 66, "title": "Chief Scientific Officer", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 416000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alireza  Javadi", "title": "Chief Technical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Bella  Vazquez", "title": "Senior Vice President of People & Administrative Services", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kate  McKinley M.B.A.", "age": 48, "title": "Chief Business Officer", "yearBorn": 1977, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Betsy  Gutierrez", "title": "Senior Vice President of Quality Assurance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Arvinder  Dhalla", "title": "Vice President of Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.35, "open": 1.38, "dayLow": 1.29, "dayHigh": 1.3887, "regularMarketPreviousClose": 1.35, "regularMarketOpen": 1.38, "regularMarketDayLow": 1.29, "regularMarketDayHigh": 1.3887, "payoutRatio": 0.0, "beta": 0.419, "forwardPE": -4.2946916, "volume": 1248620, "regularMarketVolume": 1248620, "averageVolume": 18995675, "averageVolume10days": 2085270, "averageDailyVolume10Day": 2085270, "bid": 1.03, "ask": 1.39, "bidSize": 2, "askSize": 2, "marketCap": 166797936, "fiftyTwoWeekLow": 0.387, "fiftyTwoWeekHigh": 3.87, "allTimeHigh": 36.27, "allTimeLow": 0.387, "priceToSalesTrailing12Months": 138.99828, "fiftyDayAverage": 1.7061, "twoHundredDayAverage": 0.973395, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 141953056, "profitMargins": 0.0, "floatShares": 74952625, "sharesOutstanding": 97550981, "sharesShort": 12827731, "sharesShortPriorMonth": 8312590, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.13149999, "heldPercentInsiders": 0.057329997, "heldPercentInstitutions": 0.2767, "shortRatio": 4.75, "shortPercentOfFloat": 0.1356, "impliedSharesOutstanding": 122645534, "bookValue": -0.164, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -28315000, "trailingEps": -0.77, "forwardEps": -0.31667, "enterpriseToRevenue": 118.294, "enterpriseToEbitda": -3.545, "52WeekChange": -0.087248325, "SandP52WeekChange": 0.14778805, "quoteType": "EQUITY", "currentPrice": 1.36, "targetHighPrice": 11.0, "targetLowPrice": 7.0, "targetMeanPrice": 9.25, "targetMedianPrice": 9.5, "recommendationKey": "none", "numberOfAnalystOpinions": 4, "totalCash": 4144000, "totalCashPerShare": 0.042, "ebitda": -40039000, "totalDebt": 17554000, "quickRatio": 0.216, "currentRatio": 0.259, "totalRevenue": 1200000, "revenuePerShare": 0.032, "returnOnAssets": -0.95518994, "grossProfits": 1200000, "freeCashflow": -11604375, "operatingCashflow": -27663000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -34.1825, "financialCurrency": "USD", "symbol": "RANI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1627651800000, "postMarketChangePercent": 0.0, "postMarketPrice": 1.36, "postMarketChange": 0.0, "regularMarketChange": 0.00999999, "regularMarketDayRange": "1.29 - 1.3887", "regularMarketChangePercent": 0.74074, "regularMarketPrice": 1.36, "marketState": "CLOSED", "shortName": "Rani Therapeutics Holdings, Inc", "longName": "Rani Therapeutics Holdings, Inc.", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 18995675, "fiftyTwoWeekLowChange": 0.97300005, "fiftyTwoWeekLowChangePercent": 2.5142121, "fiftyTwoWeekRange": "0.387 - 3.87", "fiftyTwoWeekHighChange": -2.5099998, "fiftyTwoWeekHighChangePercent": -0.64857876, "fiftyTwoWeekChangePercent": -8.724833, "earningsTimestampStart": 1763067600, "earningsTimestampEnd": 1763067600, "earningsCallTimestampStart": 1743453000, "earningsCallTimestampEnd": 1743453000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.77, "epsForward": -0.31667, "epsCurrentYear": -0.43667, "priceEpsCurrentYear": -3.11448, "twoHundredDayAverageChangePercent": 0.3971718, "corporateActions": [], "postMarketTime": 1767401861, "regularMarketTime": 1767387600, "exchange": "NGM", "messageBoardId": "finmb_242425883", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "fiftyDayAverageChange": -0.34609997, "fiftyDayAverageChangePercent": -0.20286031, "twoHundredDayAverageChange": 0.38660502, "priceToBook": -8.292683, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-30", "cryptoTradeable": false, "displayName": "Rani Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-01-03"}]